Phase I safety, tolerability, and pharmacokinetic trial of CVT 301 in healthy volunteers.

Trial Profile

Phase I safety, tolerability, and pharmacokinetic trial of CVT 301 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2012

At a glance

  • Drugs Levodopa (Primary) ; Levodopa (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 30 Oct 2012 New trial record
    • 15 Oct 2012 Results will be presented at the Sixth Annual Parkinson's Disease Therapeutics Conference according to a Civitas Therapeutics media release. Brief results were also summarised in the media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top